Therapeutic synergism between low-dose FK 506 and antimetabolites in rat allogeneic heart transplantation.
Tanabe
M
M
Pittsburgh Transplant Institute, University of Pittsburgh Medical Center, PA 15213.
Todo
S
S
Murase
N
N
Irish
W
W
Miyazawa
H
H
Fujisaki
S
S
Starzl
T E
TE
D000818:Animals; D001379:Azathioprine / Q000627:therapeutic use*; D004357:Drug Synergism; D004359:Drug Therapy, Combination; D006085:Graft Survival / Q000187:drug effects; D016027:Heart Transplantation / Q000276:immunology / Q000502:physiology*; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D008297:Male; D009173:Mycophenolic Acid / Q000031:analogs & derivatives* / Q000627:therapeutic use; D051381:Rats; D011912:Rats, Inbred ACI; D011917:Rats, Inbred Lew; D012263:Ribonucleosides / Q000627:therapeutic use*; D016559:Tacrolimus / Q000627:therapeutic use*; D014184:Transplantation, Homologous
D007166:Immunosuppressive Agents; D012263:Ribonucleosides; C010052:mizoribine; D009173:Mycophenolic Acid; D001379:Azathioprine; D016559:Tacrolimus